Skip to main content

Home
Specialties
Resources
CME

Search Videos and More

search

Channel Categories

Breast Cancer (3)
Cancer Screening and Survivorship (2)
Cell Therapy (15)
Clinical Trials (4)
COVID-19 (2)
Gastrointestinal Cancer (2)
Genitourinary Cancer (2)
Gynecologic Oncology (2)
Head and Neck Cancer (2)
Hematologic Oncology (8)
Immunotherapy (37)
Neuro-Oncology (2)
Pediatric Hematology/Oncology (2)
Primary Care (2)
Radiation Oncology (2)
Skin Cancer (2)
Thoracic Cancer (3)
Young Adult Malignancies (2)

Types

News (26)
Video Asset (11)

Showing 25 - 36 of 37 results

Previous| 1... 2 | 3 | 4 |Next

Neurological Effects of Immunotherapy

Neurological Effects of Immunotherapy

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

New CAR T-Cell Therapy Approved and Available at Roswell Park for Lymphoma Patients

New CAR T-Cell Therapy Approved and Available at Roswell Park for Lymphoma Patients

Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19

Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19

Is Your Patient Immunocompromised?

Is Your Patient Immunocompromised?

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Roswell Park’s Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

Roswell Park Finds New Evidence That Inhaled Vitamin E Acetate Caused EVALI in Vapers

Roswell Park Finds New Evidence That Inhaled Vitamin E Acetate Caused EVALI in Vapers

Roswell Park Earns Distinction for Cellular Immunotherapy Through BlueCross BlueShield

Roswell Park Earns Distinction for Cellular Immunotherapy Through BlueCross BlueShield

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Roswell Park Moving Unique Immunotherapy Platform Forward With $6.42 Million DoD Grant

Managing Toxicities of Immunotherapy

Managing Toxicities of Immunotherapy

Showing 25 - 36 of 37 results

Previous| 1... 2 | 3 | 4 |Next

BROADCASTMED
BroadcastMed Privacy Policy

Medical Disclaimer